Mometasone Eg (Mometasone Furoate)

Mometasone Furoate, the active ingredient in Mometasone Eg, is a corticosteroid presented as a nasal spray for nasal use. It reduces inflammation of the nasal passages and is indicated for conditions such as allergic rhinitis and nasal polyps in adults and children. GNH USA supplies Mometasone Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone Eg is a nasal corticosteroid that targets inflammatory processes of the upper airway. - Allergic rhinitis: relieves nasal congestion, itching, sneezing and rhinorrhea caused by seasonal or perennial allergens. - Nasal polyps: decreases polyp size and improves airflow, reducing obstruction and associated symptoms. - Non‑allergic rhinitis: mitigates chronic nasal inflammation and associated discharge or congestion.

Mometasone Eg may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation - Epistaxis (nosebleeds) - Headache - Altered taste or bitter taste - Throat irritation or dryness - Cough

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes or cataract formation - Adrenal suppression with prolonged use - Fungal infection of the nasal passages - Increased intra‑ocular pressure

Before initiating therapy with Mometasone Eg, consider the following safety measures. - Pregnancy: consult a healthcare professional; benefits must outweigh potential risks. - Elderly patients: monitor for systemic corticosteroid effects due to altered metabolism. - Recent nasal surgery or trauma: avoid use until complete healing to prevent impaired wound repair. - Active nasal infection: defer treatment until infection is resolved to avoid exacerbation. - Concomitant systemic corticosteroids: limit duration to reduce cumulative glucocorticoid exposure. Store at room temperature: keep in the original container, protect from moisture and heat.

Mometasone Eg can interact with other medicines that affect corticosteroid activity or metabolism.

Major Interactions (Avoid): - Systemic corticosteroids: additive glucocorticoid effects may increase systemic exposure. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local or systemic mometasone levels. - Immunosuppressants: heightened risk of infection when combined with nasal corticosteroids.

Moderate Interactions (Monitor Closely): - Antihistamines: may increase local irritation or dryness. - Nasal decongestants (e.g., oxymetazoline): concurrent use may affect mucosal healing.